Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability
Sentiment
Score
+80%
Strong Buy
10
+75%
Buy
9
+70%
Buy
8
+60%
Buy
7
+50%
Hold
6
+45%
Hold
5
+40%
Hold
4
+35%
Sell
3
+30%
Sell
2
+20%
Strong Sell
1
undefined
undefined%
At close: undefined
2.09
0.00%
After-hoursJan 06, 2025, 05:39 PM EST
Company Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines.
It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
The company is headquartered in Boston, Massachusetts.